Webinar - A change of heart: Understanding the cardiovascular effects of menopause - 12-1pm
This promotional webinar is sponsored by Theramex UK and is intended for UK Healthcare professionals only.
Webinar Details
Webinar: A change of heart: Understanding the cardiovascular effects of menopause
Wednesday 18th September, 12-1pm
This promotional webinar is sponsored by Theramex UK and is intended for UK Healthcare professionals only. Links to prescribing information and adverse event reporting can be found below.
Key points:
- It is often assumed that CVD is worse in men than in women. However, CVD is the leading cause of death in women globally,1,2 with coronary heart disease causing twice as many female deaths as breast cancer in the UK.3
- Despite this, there is a lower awareness of the risk of CVD in women than in men.1
- The risk of CVD in women notably increases during the menopausal transition.4 As such, the menopause offers a window of opportunity in which the cardioprotective action of endogenous estrogen can be continued through hormone replacement therapy (HRT).4
Guest Speaker:
Dr Yassir Javaid MA (Cantab) FRCP FRCGP PGDip Cardiology, GPwSI Cardiology
Dr Javaid qualified from Cambridge University and completed his VTS training in Northampton. He has a specialist interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service, which had a focus on patients with heart failure and valve disease. He was also the primary care Cardiovascular lead for the East Midlands Clinical Network from 2013-2020. He was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions in the East Midlands. He is on the editorial board for the British Journal of Cardiology and a trustee of Heart Valve Voice.
References:
- Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health 2019;16
- Kaczmarek M. On the doorstep to 78:269-287
- British Heart Foundation. UK factsheet, January 2024. Available at: www.bhf.org.uk. Accessed August 2024
- Hodis H N, Mack W J. Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular 28:208-223
Job code EVOR_UK_EN_19147_v1 Date of Preparation: August 2024
Click here for Prescribing Information
